visiongain Logo.png
Global Epilepsy Therapeutics Market worth US$16.6 billion by 2031: Visiongain Reports Ltd
August 23, 2022 05:06 ET | Visiongain Reports Ltd
Global Epilepsy Therapeutics Market Forecast 2021-2031:  Market Segment by Drug Class (First Generation, Second Generation and Third Generation Drugs) By Distribution Channel (Hospital Pharmacy,...
visiongain Logo.png
Global Biosimilars and Follow-on Biologics R&D Market is projected to reach a market value of US$ 2,22,576.5 Million in 2031: Visiongain Reports Ltd
August 18, 2022 04:49 ET | Visiongain Reports Ltd
Visiongain has launched a new report Biosimilars and Follow-On Biologics Market Report 2021-2031: Forecasts by Type of Manufacturing (In-House, CMOs), by Type (Monoclonal Antibodies, Fusion...
visiongain Logo.png
Global Meningococcal Vaccines Market is projected to reach a market value of US$ 6,347.5 Million by 2031: Visiongain Reports Ltd
August 18, 2022 04:34 ET | Visiongain Reports Ltd
Visiongain has published a new report on Global Meningococcal Vaccines Market Report Forecast 2021-2031. Forecasts by Market Segment by Vaccine Type (Conjugate, Polysaccharide and Others) Market...
visiongain Logo.png
Global plasma protein therapeutics market is projected to reach a market value of US$59.58 billion in 2032: Visiongain Reports Ltd
August 15, 2022 05:09 ET | Visiongain Reports Ltd
Global Plasma Protein Therapeutics Market Forecast 2022-2032: - Market Segment by Product (Immunoglobulins, Albumin, Coagulation Factors, C1-Esterase Inhibitor (C1-INH), Other Products),...
visiongain Logo.png
Global Respiratory Drug Delivery Technologies market is projected to grow at a CAGR of 7.31% by 2032: Visiongain Reports Ltd
August 15, 2022 04:17 ET | Visiongain Reports Ltd
Visiongain has published a new report: Global Respiratory Drug Delivery Technologies Market, (COVID-19 Impact Analysis):- Market Segment by Product (Formulations and Devices), by Type (Dry Powder,...
visiongain Logo.png
The Global Biologics market is projected to grow at a CAGR of 8.82% By 2032: Visiongain Reports Ltd
August 09, 2022 05:26 ET | Visiongain Reports Ltd
Visiongain has published a new report entitled the Biologics Market 2022-2032. It includes profiles of Biologics and Forecasts Market Segment by Product Type (Monoclonal Antibodies, Vaccines,...
visiongain Logo.png
Global biosimilar monoclonal antibodies market is projected to grow at a CAGR of 23.5% by 2032: Visiongain Reports Ltd
August 03, 2022 05:42 ET | Visiongain Reports Ltd
Visiongain has published a new report entitled Biosimilar Monoclonal Antibodies 2022-2032. It includes profiles of Biosimilar Monoclonal Antibodies and Forecasts Market Segment by Type (Synthetic...
visiongain Logo.png
Global precision medicine market is projected to grow at a CAGR of 10.8% by 2032: Visiongain Reports Ltd
July 21, 2022 04:39 ET | Visiongain Reports Ltd
 Visiongain has published a new report entitled Precision Medicine 2022-2032. It includes profiles of precision medicine and Forecasts Market Segment by Product Type (Diagnostics, {Genetic tests, ...
visiongain Logo.png
Global Veterinary Vaccines market is projected to grow at a CAGR of 9.0% By 2032: Visiongain Reports Ltd
June 29, 2022 05:00 ET | Visiongain Reports Ltd
Visiongain has published a new report entitled the Veterinary Vaccines Market Report 2022-2032: Forecasts by Companion Animal (Dogs, Cats), by Technology (Live Attenuated Vaccines, Inactivated...
visiongain Logo.png
Global Rare Disease Market Research Report Up to 2031: Visiongain Research Inc
April 13, 2022 11:00 ET | Visiongain Ltd
Visiongain has published a new report on “Rare Disease Market Forecast 2021-2031: By Drugs (Revlimid, MabThera/Rituxan, Opdivo, Imbruvica, Sprycel, Tasigna, Copaxone,Rebif, Gleevec, Velcade, Others),...